Overview
?
Shepherd Smith, Thomas
See more contacts
Scientific Research and Development Services
,
Business Support Services
,
Basic Chemical Manufacturing
,
Other Chemical Product and Preparation Manufacturing
,
Pharmaceutical and Medicine Manufacturing
See All Industries , Other Miscellaneous Retailers , Architectural, Engineering, and Related Services , Biotechnical research, commercial , Commercial physical research , Business services, nec , Industrial organic chemicals, nec , Chemical preparations, nec , Medicinals and botanicals , Pharmaceutical preparations , Miscellaneous retail stores, nec , Food testing service Testing laboratories, nec
See Fewer Industries
See All Industries , Other Miscellaneous Retailers , Architectural, Engineering, and Related Services , Biotechnical research, commercial , Commercial physical research , Business services, nec , Industrial organic chemicals, nec , Chemical preparations, nec , Medicinals and botanicals , Pharmaceutical preparations , Miscellaneous retail stores, nec , Food testing service Testing laboratories, nec
See Fewer Industries
Accounting, Tax Preparation, Bookkeeping, and Payroll Services
,
Advertising, Public Relations, and Related Services
,
Architectural, Engineering, and Related Services
,
Computer Systems Design and Related Services
,
Legal Services
,
Management, Scientific, and Technical Consulting Services
,
Other Professional, Scientific, and Technical Services
,
Specialized Design Services
?
?
Actual
$3.24 million
Actual
44.15%
$97
DEC
?
?
Warsaw:CTX
Contacts
Get in Touch with 8 Principals*
-
Shepherd Smith, ThomasPresident of the Board of Directors
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2023
$3.24 million
USD
Actual
1 USD = 4.0733 PLN
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net Operating Cash | -$13 | -$6 | -$7 |
| Net Investing Cash | $5 | -$4 | -$1 |
| Net Financing Cash | $9 | -$2 | $35 |
| Net Change in Cash | $1 | -$12 | $26 |
| Cash at Beginning of Period | $17 | $29 | $3 |
| Cash at End of Period | $19 | $17 | $29 |
| Capital Expenditure | -$1 | -$0 | -$1 |
| Assets (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $19 | $17 | $29 |
| Accounts Receivable | $2 | $0 | $0 |
| Inventories | $ | $ | $ |
| Other Current Assets | $2 | $7 | $3 |
| Asset Summary | |||
| Total Current Assets | $22 | $25 | $32 |
| Tangible Fixed Assets | $2 | $3 | $3 |
| Intangible Assets | $0 | $0 | $0 |
| Total Assets | $97 | $113 | $144 |
| Liabilities (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $2 | $1 | $1 |
| Short-Term Debt | $ | $ | $ |
| Other Current Liabilities | $5 | $2 | $3 |
| Liability Summary | |||
| Total Current Liabilities | $7 | $3 | $4 |
| Long-Term Debt | $ | $ | $ |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $7 | $4 | $5 |
| Stakeholder's Equity (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$40 | -$23 | -$14 |
| Equity Summary | |||
| Total Equity | $17 | $24 | $30 |
| Shares Outstanding | 4,645,712 | 4,168,130 | 4,127,972 |